489 NPX267, a first-in-class monoclonal antibody targeting KIR3DL3, blocks HHLA2-mediated immunosuppression and potentiates T and NK cell-mediated antitumor immunity

Regular and Young Investigator Award Abstracts(2022)

引用 0|浏览5
暂无评分
关键词
antitumor immunity,kir3dl3,immunosuppression,first-in-class,cell-mediated
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要